Appian Corporation and InsureMO Partner to Revolutionize US E&S Specialty Insurance Underwriting

Reuters
Sep 10
Appian Corporation and InsureMO Partner to Revolutionize US E&S Specialty Insurance Underwriting

Appian Corporation has announced a strategic partnership with InsureMO to deliver an innovative underwriting solution for the US Excess & Surplus (E&S) specialty insurance market. By integrating InsureMO's Excel Rater platform with Appian's AI-powered Connected Underwriting Workbench, the collaboration aims to streamline and automate the underwriting process. This joint solution provides underwriters with the tools to evaluate and price risk efficiently, reducing time to quote, minimizing risk, and enhancing customer experience. The integrated solution is now available for US E&S specialty insurers, offering seamless integration with existing systems and the capability to manage complex, high-volume business operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Appian Corporation published the original content used to generate this news brief on September 09, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10